Comparing GLP-1 Receptor Agonists with SGLT2 Inhibitors for Type 2 Diabetes Patients episode artwork

EPISODE · Apr 12, 2020 · 17 MIN

Comparing GLP-1 Receptor Agonists with SGLT2 Inhibitors for Type 2 Diabetes Patients

from HCPLive Podcasts · host HCPLive.com

Investigators from Saint Louis University discuss their recent study comparing GLP-1 receptor agonists with SGLT2 inhibitors.

Episode metadata supplied by the publisher feed · Published Apr 12, 2020

Embed this episode

NOW PLAYING

Comparing GLP-1 Receptor Agonists with SGLT2 Inhibitors for Type 2 Diabetes Patients

0:00 17:27

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of HCPLive Podcasts?

This episode is 17 minutes long.

When was this HCPLive Podcasts episode published?

This episode was published on April 12, 2020.

Can I download this HCPLive Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!